Skip to content
Home/Companies/Biotech/Adagene

Adagene

Biotech·China·Active
Entry
–
Hold
–
Status
Active

Who owns Adagene?

Adagene is a Chinese Biotech company, currently owned by General Atlantic.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
General Atlantic
Investor
General Atlantic
General Atlantic · 2020 · Growth

Key facts

HQChina
SectorBiotech

More from General Atlantic

Other portfolio companies in the same fund.

58.com
Active
E-commerceChina
A-Max
A-Max
Active
Business ServicesUS
Acko
Active
TMTIndia
Aimbridge Hospitality
Aimbridge Hospitality
Active
Business ServicesUS
AKQA
AKQA
Active
TMTUK
Alignment Healthcare
Alignment Healthcare
Active
HealthTechUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Ariceum Therapeutics GmbH
Active
Enterprise IrelandGermany

Questions

Who owns Adagene?

Adagene is currently owned by General Atlantic, through General Atlantic.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue